1.31
-0.0507(-3.73%)
Currency In USD
| Previous Close | 1.36 |
| Open | 1.39 |
| Day High | 1.4 |
| Day Low | 1.3 |
| 52-Week High | 2.63 |
| 52-Week Low | 0.77 |
| Volume | 111,037 |
| Average Volume | 191,808 |
| Market Cap | 108.21M |
| PE | -3.85 |
| EPS | -0.34 |
| Moving Average 50 Days | 1.22 |
| Moving Average 200 Days | 1.42 |
| Change | -0.05 |
If you invested $1000 in Cardiol Therapeutics Inc. (CRDL) since IPO date, it would be worth $349.93 as of July 01, 2025 at a share price of $1.309. Whereas If you bought $1000 worth of Cardiol Therapeutics Inc. (CRDL) shares 5 years ago, it would be worth $756.82 as of July 01, 2025 at a share price of $1.309.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Cardiol Therapeutics Reports Results of 2025 Annual General Meeting of Shareholders
Newsfile
May 29, 2025 11:27 AM GMT
Toronto, Ontario--(Newsfile Corp. - May 29, 2025) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on developing anti-inflammatory and anti-fibrotic therapies for the
Cardiol Therapeutics to Webcast Virtual Annual General Meeting of Shareholders on May 28th at 4:30 p.m. EDT
Newsfile
May 27, 2025 11:27 AM GMT
Toronto, Ontario--(Newsfile Corp. - May 27, 2025) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on developing anti-inflammatory and anti-fibrotic therapies for the
Cardiol Therapeutics Nominates Dr. Timothy Garnett to Its Board of Directors
Newsfile
Apr 29, 2025 11:27 AM GMT
Former Chief Medical Officer of Eli Lilly brings more than thirty years of pharmaceutical industry experienceToronto, Ontario--(Newsfile Corp. - April 29, 2025) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a cl